Spectral Diagnostics Net Profit Margin 2010-2025 | EDTXF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Spectral Diagnostics net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Spectral Diagnostics net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$180.6B
Intuitive Surgical (ISRG)	$177.8B
Edwards Lifesciences (EW)	$46.9B
IDEXX Laboratories (IDXX)	$45.5B
Alcon (ALC)	$45.3B
DexCom (DXCM)	$34.9B
IQVIA Holdings (IQV)	$33.9B
Mettler-Toledo (MTD)	$26.3B
STERIS (STE)	$22.7B
Waters (WAT)	$18B
SONOVA HOLDING (SONVY)	$17.5B
Hologic (HOLX)	$14.8B
Sysmex ADR (SSMXY)	$10.7B
Penumbra (PEN)	$9B
Masimo (MASI)	$8.9B
Globus Medical (GMED)	$7.4B
Glaukos (GKOS)	$5.4B
Teleflex (TFX)	$5.2B
Integer Holdings (ITGR)	$3.8B
TransMedics (TMDX)	$3.7B
PROCEPT BioRobotics (PRCT)	$3.1B
LivaNova (LIVN)	$2.4B
Nihon Kohden (NHNKY)	$2.1B
Elekta AB (EKTAY)	$2B
Veracyte (VCYT)	$2B
Alphatec Holdings (ATEC)	$1.6B
Artivion (AORT)	$1.3B
Paragon 28 (FNA)	$1.1B
OPKO Health (OPK)	$1.1B
Tandem Diabetes Care (TNDM)	$1.1B